This post is sponsored by MidAmerica Healthcare Venture Forum.
On March 10-11, 2015, in Chicago, the MidAmerica Healthcare Venture Forum presented by MedCity News will give active, eager angel, venture and strategic investors an opportunity to hear more than 30 promising early-stage companies pitch their product, business model or investment opportunity.
The selection committee for the MidAmerica Healthcare Venture Forum consists of real investors and industry leaders whose careers have been built on selecting winners. They have chosen more than 30 of the best early-stage privately held companies in the categories of pharma, biotech, medical devices, diagnostics, health IT and digital health to present at the conference in front of healthcare venture capitalists and other firms.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
2015 Showcase companies include:
- Biotech and Diagnostics: Biosortia Pharmaceuticals, Isomark, LLC, Metabolic Solutions Development Company, PeptiMed
- Medical Devices: Advanced Cooling Therapy, Inc., Blaze Medical Devices, Diagnostic Photonics
- Digital/Health IT: MediVu, RespondWell, UnaliWear
This is a great opportunity for investors to learn about thriving technology innovation within healthcare. Last year, companies presented in front of the likes of Baird Capital, Baxter Venture, GE Capital, Highmark Ventures, Hyde Park Angels, Lemhi Ventures, Mayo Clinic Ventures, Qualcomm Ventures and Venture Investors, among many others. You can see the 2014 showcase class here.
In addition to the company showcase, the two-day MidAmerica Healthcare Venture Forum features an agenda packed with discussion topics including digital health and innovation and thought leaders in the healthcare industry including a keynote from Karen Brown of the American Heart Association. Register now to join us.
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Check here for more information and a full agenda with speakers.
Thank you to our sponsors, GE Capital, MATTER, River Cities Capital Funds and The Domann Organization.
Photo Credit: Freedigitalphotos.net
